首页> 外文期刊>The Internet Journal of Third World Medicine >Metastatic Bone Cancer of Unknown Primary Resolved by Herbal Therapy: A Case Study
【24h】

Metastatic Bone Cancer of Unknown Primary Resolved by Herbal Therapy: A Case Study

机译:草药疗法解决未知原发性转移性骨癌的案例研究

获取原文
           

摘要

Angela, 69-year old female, was diagnosed with metastatic bone cancer of unknown primary in September 1999. She declined radiotherapy and took herbs instead. She was on herbal therapy for five years. Medical examination in August 2004 indicated that her suspected bone cancer had resolved. She is currently on medication for osteoporosis. Introduction Metastatic bone cancer originates from other primary site of the body such as breast, prostate, lung, thyroid and kidney. The bone is one of the four favourite sites that cancer cells like to anchor on after moving out of their primary site. Other organs that are targets of secondary cancer are the lung, brain and liver. Metastatic spread represents the final phase in the progression of cancer in the body (1, 2).Bone scintigraphy or commonly referred to as bone scan, is the primary imaging modality for detecting bone metastasis. In this procedure radioactive tracer will accumulate in the skeletal structures where the bone is undergoing destruction or repair, resulting in formation of “hot spots” on the film (2, 3). While bone scan is a valuable procedure that allows for rapid evaluation of the entire skeleton, it unfortunately, lacks specificity. Tracer accumulation is not only confined to cancerous tissue but also areas where there is active bone turnover such as in degenerative joints, healing of fractures or infection (3). However, an experienced radiographer should be able to provide some degree of confidence in interpreting bone scan. Bone metastasis usually involve multiple sites (i.e. three or more lesions) and the tracer uptake do not correspond to any single anatomic structure (4). MRI is another additional tool for evaluating patients with positive bone scan. It is said to be more sensitive than bone scan for detecting bone metastasis at its early stage (4). Patients with bone metastasis often suffer from lytic destruction of the spine. This is the most commonly affected site, followed by the sacrum, pelvis, fermur, skull and humerus (3, 5). The symptoms shown by patients with metastatic bone cancer include: pains, hypercalcemia and increasing disability (4, 6). Bone metastasis can also lead to serious bone fracture (5). At present, there is no cure for metastatic bone diseases (7). Case Presentation Angela (not real name), 69-year-old female, suffered from chronic pains since 1995. She consulted two doctors and both of them prescribed her painkillers. During this initial period the pains just “came and went off”. In 1998, the problem became more serious and Angela went to consult another doctor. Again she was prescribed painkillers. She took the pain tablets as and when necessary. By August 1999, the pain became too unbearable and she consulted another doctor. This time she was referred to an orthopedic surgeon, who suggested that Angela undergo a full blood test and do both a bone scan and MRI. The blood test done on 4 September 1999 indicated mild polyclonal increase in gamma globulins, consistent with chronic inflammation / infection. A bone scan done on 23 September 1999, indicated: multiple foci of increased trace accumulation involving both the sternoclavicular junctions, lower cervical vertebra, T5 or T6 vertebra, L3, right sacro-illiac joint and the right side of the lower aspect of the sternum. In view of the multiplicity of the lesions, metastasis has to be considered.MRI report of 28 September 1999, indicated: abnormal signal seen involving the T6, T7, T8, L3 and possibly L4 vertebral bodies. This signal abnormality suggest metastatic lesion involving these vertebral bodies. The T 6, T7 and T8 vertebral body shows mild loss of vertebral height anteriorly. The L3 vertebral areas show an otherwise normal configuration. Spondylotic changes of the lower lumbar vertebrae with degenerated disc area, also seen at L4 / L5 and L5 / S1 levels. Impression: Appearance suggests metastatic involvement of the T6, T7, T8 and L3 vertebral bodies. No cord compression is seen.An
机译:现年69岁的女性安吉拉(Angela)于1999年9月被诊断出患有原发性未知的转移性骨癌。她拒绝放疗,改用草药。她接受了五年的草药治疗。 2004年8月的医学检查表明,她怀疑的骨癌已经解决。她目前正在接受骨质疏松症的药物治疗。简介转移性骨癌起源于身体的其他主要部位,例如乳腺癌,前列腺癌,肺癌,甲状腺癌和肾癌。骨骼是癌细胞从原发部位移出后最喜欢锚固的四个部位之一。继发癌的其他器官是肺,脑和肝。转移性扩散代表体内癌症发展的最后阶段(1、2)。骨闪烁显像或通常称为骨扫描是检测骨转移的主要影像学手段。在此过程中,放射性示踪剂会积聚在骨骼正在受到破坏或修复的骨骼结构中,从而在薄膜上形成“热点”(2、3)。骨扫描是有价值的程序,可以快速评估整个骨骼,但不幸的是,它缺乏特异性。示踪剂的积累不仅限于癌变组织,而且还包括骨活动活跃的区域,例如变性关节,骨折愈合或感染(3)。但是,有经验的射线照相师应该能够在解释骨扫描方面提供一定程度的信心。骨转移通常涉及多个部位(即三个或更多病变),而示踪剂的吸收并不对应于任何单个解剖结构(4)。 MRI是评估骨扫描阳性患者的另一种附加工具。据说它在早期检测骨转移方面比骨扫描敏感(4)。骨转移患者经常遭受脊柱溶解性破坏。这是最容易受累的部位,其次是,骨,骨盆,股骨,颅骨和肱骨(3,5)。转移性骨癌患者表现出的症状包括:疼痛,高钙血症和残疾增加(4、6)。骨转移也可能导致严重的骨折(5)。目前,尚无治愈转移性骨病的方法(7)。病例介绍Angela(非真实姓名),现年69岁,女性,自1995年以来一直患有慢性疼痛。她咨询了两名医生,他们俩都开了止痛药。在最初的这段时期,痛苦只是“消失了”。 1998年,问题变得更加严重,Angela去咨询了另一位医生。再次给她开了止痛药。她在必要时服用了止痛药。到1999年8月,疼痛变得无法忍受,她咨询了另一位医生。这次,她被转诊至骨科医生,她建议安吉拉(Angela)接受全血检查,并进行骨扫描和MRI检查。 1999年9月4日进行的血液检查表明,γ球蛋白的多克隆轻度增加,与慢性炎症/感染相符。 1999年9月23日进行的骨扫描表明:多处痕量积聚增加,包括锁骨上交界处,下颈椎,T5或T6椎骨,L3,rightcro右侧关节和胸骨下侧面的右侧。鉴于病变的多样性,必须考虑转移。1999年9月28日的MRI报告表明:看到异常信号涉及T6,T7,T8,L3和可能的L4椎体。该信号异常提示累及这些椎体的转移性病变。 T 6,T7和T8椎体前部椎体高度轻度丧失。 L3椎骨区域显示其他正常配置。下腰椎椎体的椎间盘变性随椎间盘区域的退化而变化,在L4 / L5和L5 / S1水平也可见。印象:外观提示T6,T7,T8和L3椎体转移受累。没有看到电线受压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号